Loading
Cutting out the part of the liver containing tumour. The liver regrows, so up to 70% can be removed if what remains is healthy.
Used for hepatocellular carcinoma in patients with preserved liver function (Child-Pugh A, no portal hypertension), for cholangiocarcinoma, and for colorectal liver metastases, where resection gives 5-year survival of 40-50% and is the only curative option. Portal vein embolisation or two-stage hepatectomy grows the future liver remnant before surgery; ablation handles small lesions. Anatomical segments (Couinaud) define the resection; a margin of even 1 mm is acceptable in metastases.
Showing the technology this term belongs to: Thermal ablation (RFA, microwave, cryo).
Shares Belfast Health and Social Care Trust HPB service, Derriford Hospital, University Hospitals Plymouth, King's College Hospital, London, Morriston Hospital, Swansea.
Shares Belfast Health and Social Care Trust HPB service, King's College Hospital, London, Royal Infirmary of Edinburgh, University Hospital of Wales, Cardiff.
Shares CLOCC, Liver-directed therapy (TACE, TARE, HAI, ablation), Early hepatocellular carcinoma (BCLC 0 and A), Thermal ablation (RFA, microwave, cryo).
Shares Downstaging and conversion therapy, Liver-directed therapy (TACE, TARE, HAI, ablation), Grade 3 well-differentiated neuroendocrine tumour, Early hepatocellular carcinoma (BCLC 0 and A).
Shares Child-Pugh score, Downstaging and conversion therapy, Early hepatocellular carcinoma (BCLC 0 and A), Thermal ablation (RFA, microwave, cryo).
Shares Derriford Hospital, University Hospitals Plymouth, Morriston Hospital, Swansea, Glasgow Royal Infirmary, Liverpool University Hospitals HPB centre (Aintree).
Shares Derriford Hospital, University Hospitals Plymouth, Addenbrooke's Hospital, Cambridge University Hospitals, Extrahepatic cholangiocarcinoma (perihilar and distal), Intrahepatic cholangiocarcinoma.
Shares Segment IVb and V liver resection (versus wedge resection), NEOGB, Surgery for gallbladder cancer: simple versus radical cholecystectomy, re-resection and lymphadenectomy, OPT-IN (EA2197).